Myocardial Ischemia and Cardioprotection: From Pathophysiology to Novel Therapeutic Targets
Year: 2026
Type: article
Abstract: Ischemic heart disease remains the leading cause of death worldwide and is frequently complicated by myocardial ischemia–reperfusion (I/R) injury, which contributes substantially to infarct expansion, adverse ventricular remodeling, and heart failure. The pathophysiology of myocardial ischemia involves a complex interplay among energy depletion, intracellular acidosis, calcium overload, oxidative stress, mitochondrial dysfunction, and the activation of apoptotic, necroptotic, pyroptotic, and ferroptotic cell death pathways. Endogenous cardioprotective mechanisms, including ischemic preconditioning, postconditioning, remote ischemic conditioning, heat shock proteins, bilirubin signaling, and mitochondrial quality-control pathways, have demonstrated potent infarct-limiting effects in experimental models. These protective responses are mediated through interconnected signaling networks which converge to preserve mitochondrial integrity, maintain calcium homeostasis, reduce oxidative stress, and enhance cell survival. In addition, innate and adaptive immune responses play critical roles in post-infarction repair and remodeling, although excessive and/or prolonged inflammation can exacerbate injury. Despite strong mechanistic evidence, the translation of cardioprotective therapies into clinical practice has been challenging due to comorbidities, patient heterogeneity, and the complexity of human disease. Emerging approaches, including mitochondrial-targeted antioxidants, cell-based therapies, anti-inflammatory interventions, ferroptosis inhibitors, and SGLT2 inhibitors, offer promising opportunities for developing effective, multifaceted cardioprotective strategies.
Language: English
Subfield: Cardiology and Cardiovascular Medicine
Field: Medicine
Domain: Health Sciences
Keywords: myocardial ischemia, ischemia-reperfusion injury, cardioprotection, mitochondrial dysfunction, oxidative stress, calcium overload, ferroptosis, necroptosis, pyroptosis, apoptosis, ischemic preconditioning, postconditioning, remote ischemic conditioning, heat shock proteins, mitochondrial quality control, cardiac inflammation, infarct expansion, ventricular remodeling, cell therapy, ferroptosis inhibitors, SGLT2 inhibitors, mitochondria-targeted antioxidants, anti-inflammatory therapy
Open Access status: gold
Estimated APC paid: $3,499
OpenAlex ID: W7236612796
